JP5064226B2 - 不眠症の治療において有用な新規な製剤処方 - Google Patents

不眠症の治療において有用な新規な製剤処方 Download PDF

Info

Publication number
JP5064226B2
JP5064226B2 JP2007538505A JP2007538505A JP5064226B2 JP 5064226 B2 JP5064226 B2 JP 5064226B2 JP 2007538505 A JP2007538505 A JP 2007538505A JP 2007538505 A JP2007538505 A JP 2007538505A JP 5064226 B2 JP5064226 B2 JP 5064226B2
Authority
JP
Japan
Prior art keywords
formulation
zolpidem
optimum
tablet
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007538505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517988A5 (https=
JP2008517988A (ja
Inventor
アンダース・ペッテルソン
クリスター・ニストレム
スザンヌ・ブレデンベルグ
Original Assignee
オレクソ・アクチエボラゲット
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オレクソ・アクチエボラゲット filed Critical オレクソ・アクチエボラゲット
Publication of JP2008517988A publication Critical patent/JP2008517988A/ja
Publication of JP2008517988A5 publication Critical patent/JP2008517988A5/ja
Application granted granted Critical
Publication of JP5064226B2 publication Critical patent/JP5064226B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2007538505A 2004-10-27 2005-10-26 不眠症の治療において有用な新規な製剤処方 Expired - Lifetime JP5064226B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0423800.2 2004-10-27
GBGB0423800.2A GB0423800D0 (en) 2004-10-27 2004-10-27 New pharmaceutical formulations
PCT/GB2005/004147 WO2006046041A1 (en) 2004-10-27 2005-10-26 New pharmaceutical formulations useful in the treatment of insomnia

Publications (3)

Publication Number Publication Date
JP2008517988A JP2008517988A (ja) 2008-05-29
JP2008517988A5 JP2008517988A5 (https=) 2008-12-11
JP5064226B2 true JP5064226B2 (ja) 2012-10-31

Family

ID=33515600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538505A Expired - Lifetime JP5064226B2 (ja) 2004-10-27 2005-10-26 不眠症の治療において有用な新規な製剤処方

Country Status (13)

Country Link
US (4) US9265720B2 (https=)
EP (2) EP1807156B1 (https=)
JP (1) JP5064226B2 (https=)
CY (2) CY1118414T1 (https=)
DK (2) DK2340872T3 (https=)
ES (1) ES2610469T3 (https=)
GB (1) GB0423800D0 (https=)
HU (1) HUE030609T2 (https=)
LT (2) LT2340872T (https=)
PL (2) PL2340872T3 (https=)
PT (2) PT1807156T (https=)
SI (2) SI1807156T1 (https=)
WO (1) WO2006046041A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5179757B2 (ja) 2004-02-17 2013-04-10 トランセプト ファーマシューティカルズ， インコーポレイティド 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
EP1883408A4 (en) * 2005-05-25 2009-11-11 Transcept Pharmaceuticals Inc SOLID COMPOSITIONS AND METHODS FOR TREATMENT OF INSOMNIA IN THE NIGHT
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
WO2008067549A2 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized zolpidem pharmaceutical compositions
WO2008075372A1 (en) * 2006-12-18 2008-06-26 Lupin Limited Controlled release dosage forms of zolpidem
CN101801346A (zh) * 2007-05-10 2010-08-11 诺瓦德尔药品公司 抗失眠症组合物及方法
TR201808694T4 (tr) * 2008-06-20 2018-07-23 Merck Patent Gmbh Doğrudan sıkıştırılabilen ve hızlı parçalanan tablet matrisi.
BRPI1012170A2 (pt) * 2009-05-20 2016-03-29 Lingual Consegna Pty Ltd formulação e/ou sublingual e método para reduzir a quantidade de composto ativo usado para alcançar um efeito em um paciente em comparação com um composto típico que é ingerido.
CN105581991A (zh) * 2015-12-28 2016-05-18 安徽省逸欣铭医药科技有限公司 一种酒石酸唑吡坦舌下片及其制备方法
SG11202103255RA (en) 2018-10-08 2021-04-29 Troikaa Pharmaceuticals Ltd Oromucosal solutions of zolpidem or pharmaceutically acceptable salts thereof
CN111939133A (zh) * 2019-05-16 2020-11-17 鲁南制药集团股份有限公司 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
SE8800080L (sv) 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8803935L (sv) 1988-10-31 1990-05-01 Kabivitrum Ab Laekemedelskomposition
JPH0665103A (ja) * 1992-08-13 1994-03-08 ▲寛▼治 ▲高▼田 向精神薬のための速吸収性舌下投与製剤
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
AU7937500A (en) * 1999-10-27 2001-05-08 Farmarc Nederland Bv Pharmaceutical composition containing midazolam
AU5066101A (en) * 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent
CN1290525A (zh) 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US20040176359A1 (en) 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
AU2002259241B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of sedative-hypnotics through an inhalation route
ES2301797T3 (es) * 2002-01-10 2008-07-01 Biovail Laboratories International Srl Formulaciones sedantes no benzodiazepinicas.
JP4551092B2 (ja) 2002-03-06 2010-09-22 協和発酵キリン株式会社 口腔内速崩壊性錠剤
US20050208127A1 (en) 2002-06-10 2005-09-22 Kazuyoshi Ogasawara Rapidly disintegrating tablet and process for producing the same
ES2199061B1 (es) 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
CN1418631A (zh) 2002-12-19 2003-05-21 王登之 治疗失眠的佐匹克隆口腔崩解片及其制备方法
US20040265375A1 (en) 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
WO2004100857A2 (en) * 2003-05-07 2004-11-25 Akina, Inc. Highly plastic granules for making fast melting tablets
WO2005063248A1 (en) * 2003-12-22 2005-07-14 Sepracor Inc. Modafinil combination therapy for improving sleep quality
NZ548856A (en) 2004-02-17 2009-10-30 Transcept Pharmaceuticals Inc Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
JP5179757B2 (ja) * 2004-02-17 2013-04-10 トランセプト ファーマシューティカルズ， インコーポレイティド 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
CN1290525C (zh) * 2004-07-13 2006-12-20 赵余庆 一种降血糖的植物提取物及其用途

Also Published As

Publication number Publication date
US20080311208A1 (en) 2008-12-18
CY1119580T1 (el) 2018-03-07
GB0423800D0 (en) 2004-12-01
ES2610469T3 (es) 2017-04-27
PT1807156T (pt) 2017-01-19
US20110268796A1 (en) 2011-11-03
EP2340872A1 (en) 2011-07-06
HUE030609T2 (en) 2017-05-29
EP1807156B1 (en) 2016-10-12
LT1807156T (lt) 2016-12-12
LT2340872T (lt) 2017-09-11
US20130230589A1 (en) 2013-09-05
US9597281B2 (en) 2017-03-21
PL2340872T3 (pl) 2017-12-29
SI2340872T1 (sl) 2017-10-30
JP2008517988A (ja) 2008-05-29
CY1118414T1 (el) 2017-06-28
US9265720B2 (en) 2016-02-23
WO2006046041A1 (en) 2006-05-04
PL1807156T3 (pl) 2017-06-30
SI1807156T1 (sl) 2017-01-31
DK2340872T3 (en) 2017-09-18
EP2340872B1 (en) 2017-07-05
PT2340872T (pt) 2017-10-06
EP1807156A1 (en) 2007-07-18
US20120277261A1 (en) 2012-11-01
DK1807156T3 (en) 2017-01-23

Similar Documents

Publication Publication Date Title
US9597281B2 (en) Pharmaceutical formulations useful in the treatment of insomnia
CN102387802B (zh) 包含羟考酮和纳洛酮的立即释放药物组合物
JP4920798B2 (ja) ２種以上の粒子を含有する口腔内速崩壊錠
EP1809251A2 (en) Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
KR20140075682A (ko) 오피오이드 의존증의 치료를 위한 남용-방지성 약학 조성물
JP2009114113A (ja) 口腔内崩壊錠及びその製造方法
JP2001058944A (ja) 速崩壊性固形製剤
EP3389625B1 (en) Quick dissolving diphenhydramine oral dosage form
JP2003034655A (ja) 速崩壊性固形製剤
KR20150005695A (ko) 급성 통증을 치료하기 위한 신규한 알펜타닐 조성물
JP6061924B2 (ja) 口腔内分散性製剤
US20130143912A1 (en) Sublingual zolpidem formulations
ES2642213T3 (es) Nuevas formulaciones farmacéuticas útiles en el tratamiento del insomnio
CA3256514A1 (en) PHLOROGLUCINOL FORMULATIONS AND METHODS OF USE

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081024

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081024

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120209

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120515

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120515

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120710

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120808

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5064226

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150817

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term